Patent Term Extension under 35 U.S.C. §156 is Limited to the FDA-Approved Active Ingredient and Salts or Esters thereof—but not Metabolites or Compounds Sharing an Active Moiety
May 13, 2020
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.
